Hyaluronan content in experimental carcinoma is not correlated to interstitial fluid pressure

被引:9
作者
Jacobson, A
Salnikov, A
Lammerts, E
Roswall, P
Sundberg, C
Heldin, P
Rubin, K
Heldin, NE [1 ]
机构
[1] Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[2] Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden
[3] Biomed Ctr, Ludwig Inst Canc Res, SE-75123 Uppsala, Sweden
关键词
ATC; colon adenocarcinoma; TGF-beta; xenograft tumors;
D O I
10.1016/S0006-291X(03)00872-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mechanism(s) for generation of the high tumor interstitial fluid pressure (TIFP) that is characteristic of carcinoma is not known. We investigated the role of hyaluronan, the major water-binding polysaccharide of the extracellular matrix, for the generation of a high TIFP. A human anaplastic thyroid carcinoma (KAT-4) xenografted to athymic mice and a syngeneic rat colon carcinoma (PROb) were used. Neither KAT-4 nor PROb cells produced hyaluronan (HA) in culture, however, both cell lines produced factors that stimulated HA-synthesis by cultured fibroblasts. Modulating hyaluronan levels by transfection of PROb carcinoma cells with hyaluronan synthase-2 revealed no correlation between hyaluronan content and TIFP. Furthermore, lowering of TIFP by treating KAT-4 tumors with a specific inhibitor of TGF-beta1 and -beta3 did not change the concentration of hyaluronan in the tumors. In summary. our results suggest that a modulation of hyaluronan content is not a major pathogenetic mechanism for the generation of the characteristically high TIFP in malignant carcinomas. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1017 / 1023
页数:7
相关论文
共 50 条
[41]  
Rubin K, 2000, INT J CANCER, V86, P636, DOI 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO
[42]  
2-R
[43]   Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth [J].
Smith, JD ;
Bryant, SR ;
Couper, LL ;
Vary, CPH ;
Gotwals, PJ ;
Koteliansky, VE ;
Lindner, V .
CIRCULATION RESEARCH, 1999, 84 (10) :1212-1222
[44]   Molecular cloning and characterization of a putative mouse hyaluronan synthase [J].
Spicer, AP ;
Augustine, ML ;
McDonald, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23400-23406
[45]   Hyaluronan and homeostasis: A balancing act [J].
Tammi, MI ;
Day, AJ ;
Turley, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :4581-4584
[46]   Hyaluronan-cell interactions in cancer and vascular disease [J].
Toole, BP ;
Wight, TN ;
Tammi, MI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :4593-4596
[47]  
Wapnir IL, 1996, INVAS METAST, V16, P308
[48]  
WIIG H, 1982, SCAND J CLIN LAB INV, V42, P159
[49]   New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences [J].
Wiig, H ;
Rubin, K ;
Reed, RK .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (02) :111-121
[50]   Recombinant soluble transforming growth factor β type II receptor ameliorates radiation enteropathy in mice [J].
Zheng, H ;
Wang, JR ;
Koteliansky, VE ;
Gotwals, PJ ;
Hauer-Jensen, M .
GASTROENTEROLOGY, 2000, 119 (05) :1286-1296